Concerning NSCLC, it has already been reported in vitro that A549 cells treated with the chemotherapeutic agents, adriamycin and 9NC, increased RKIP expression in a time and dose dependent manner. This evidence concerns the gene PEBP1 and non-small cell lung carcinoma.